Celldex (CLDX) Tops Q2 EPS by 4c

Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $1.05 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue